What are GSK top selling products?
GSK is ranked number 6 among the top 20 pharma companies by revenue in 2019, according to FiercePharma. The British pharmaceutical company is well-known for products like Advair, Ventolin, Theraflu, Advil and Centrum.
Is GSK a Nigerian?
Global Manufacturing and Supply (GMS) GMS is the manufacturing unit of GSK Consumer Nigeria Plc. It is located in Agbara, Ogun State.
What drugs do GSK produce?
Products
- Anoro ▼ Ellipta (umeclidinium/vilanterol inhalation powder)
- Avamys (fluticasone furoate)
- Bexsero (Meningococcal group B Vaccine (rDNA, component, adsorbed))
- Dovato (dolutegravir/lamivudine)
- Ellipta inhaler (device information)
- Incruse ▼ Ellipta (umeclidinium bromide)
- Nucala (mepolizumab)
What companies do GSK own?
GlaxoSmithKline
- SmithKline Beecham Plc (Renamed 1989) SmithKline Beckman (Renamed 1982)
- Glaxo Wellcome. Glaxo (Merged 1995)
- Block Drug (Acquired 2001)
- CNS Inc. ( Acquired 2006)
- Stiefel Laboratories (Acquired 2009)
- Laboratorios Phoenix (Acquired 2010)
- Maxinutrition (Acquired 2010)
- CellZome (Acquired 2011)
How many products does GSK sell?
62 products as selected for analysis by the Index† GSK has 39 medicines in scope, 21 of which are on patent, and 22 vaccines.
What is the biggest selling drug?
Pfizer’s cholesterol-lowering drug Lipitor is by far the best-selling drug of all time.
Who are the registrars for glaxosmithkline?
Our Registrars for Ordinary Shareholders are Equiniti Limited, and our Depositary Bank for ADR holders is JPMorgan Chase Bank (JPM). They look after our register and are responsible for ensuring that shareholder details are recorded accurately.
What is the use of GlaxoSmithKline tablet?
Manufactured byGlaxosmithkline Pharmaceuticals Ltd. Dapsone (GSK) 25 mg Tablet is an antibacterial agent used along with other medicines (multi-drug regimen) for the treatment of all forms of leprosy, a long-term infection caused by Mycobacterium leprae or Mycobacterium lepromatosis.
What is the top selling GSK OTC brand?
Well-known brands to be sold under the JV include GSK’s Voltaren and Panadol, and Pfizer’s Advil, Nexium 24HR and Robitussin. According to GSK, the JV “will be the global leader in over-the-counter (OTC) products with a market share of 7.3% ahead of its nearest competitor at 4.1%”.
What medication makes the most money?
Humira – $19.9bn Humira generated almost 61% of the total revenue of Abbvie in 2018, and it is their largest and most profitable product. With net sales growing by 7% worldwide in 2018, the drug which helps in the treatment of rheumatoid arthritis is the company’s biggest hope.
Who owns GSK?
As previously announced, under the terms of the transaction, Pfizer owns a 32% equity stake in the joint venture and GSK owns 68%. The combined business, which will operate globally as GSK Consumer Healthcare, will be led by CEO Brian McNamara.
How can I invest in GSK?
How to buy shares in GSK
- Choose a platform. If you’re a beginner, our share-dealing table below can help you choose.
- Open your account.
- Confirm your payment details.
- Search the platform for stock code: GSK in this case.
- Research GSK shares.
- Buy your GSK shares.
How many products does GSK produce?
62 products as selected for analysis by the Index† GSK has 39 medicines in scope, 21 of which are on patent, and 22 vaccines. 49% of these medicines (19) are on WHO’s EML. In addition, the company markets 1 platform technology.
Does GSK make Metformin?
GlaxoSmithKline announces FDA approval and the launch of Avandamet (rosiglitazone maleate and metformin HCl) as inital therapy in the treatment of type 2 diabetes. This is press announcement from GSK.
What toothpaste do GSK make?
GSK Consumer Healthcare (GSKCH), the world-leading consumer healthcare business, announced today that it is partnering with two global packaging suppliers to launch fully recyclable toothpaste tubes across its specialist and science-based oral health brands, including Sensodyne, parodontax and Aquafresh.
Which medication made the most money?
Best selling pharmaceuticals of U.S. Market
| Rank | Drug | 2019 |
|---|---|---|
| 1 | adalimumab | 21.4 |
| 2 | apixaban | 9.9 |
| 3 | etanercept | 8.1 |
| 4 | ustekinumab | 6.6 |